Zelnorm Will Be Available Under Treatment IND Following Marketing Suspension
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis voluntarily suspends marketing of the irritable bowel syndrome medication due to cardiovascular events.
You may also be interested in...
Novartis Further Restricts Access To Zelnorm
Irritable bowel syndrome therapy available in U.S. only for emergencies.
Novartis Further Restricts Access To Zelnorm
Irritable bowel syndrome therapy available in U.S. only for emergencies.
Zelnorm Treatment IND Limited To Women Under 55
Protocol also restricts use to women whose physicians deem the irritable bowel medication medically necessary.